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Background: Binge eating disorder is a prevalent adolescent disorder, associated with increased eating disorder
and general psychopathology as well as an increased risk for overweight and obesity. As opposed to binge eating
disorder in adults, there is a lack of validated psychological treatments for this condition in adolescents. The goal of
this research project is therefore to determine the efficacy of age-adapted cognitive-behavioral therapy in
adolescents with binge eating disorder – the gold standard treatment for adults with binge eating disorder.
Methods/design: In a single-center efficacy trial, 60 12- to 20-year-old adolescents meeting diagnostic criteria of binge
eating disorder (full-syndrome or subthreshold) according to the Diagnostic and Statistical Manual of Mental Disorders
4th or 5th Edition, will be centrally randomized to 4 months of cognitive-behavioral therapy (n = 30) or a waiting-list
control condition (n = 30). Using an observer-blind design, patients are assessed at baseline, mid-treatment,
post-treatment, and at 6- and 12-month follow-ups after the end of treatment. In 20 individual outpatient sessions,
cognitive-behavioral therapy for adolescents focuses on eating behavior, body image, and stress; parents receive
psychoeducation on these topics. Primary endpoint is the number of episodes with binge eating over the previous 28
days at post-treatment using a state-of-the art clinical interview. Secondary outcome measures address the specific eating
disorder psychopathology, general psychopathology, mental comorbidity, self-esteem, quality of life, and body weight.
Discussion: This trial will allow us to determine the short- and long-term efficacy of cognitive-behavioral therapy in
adolescent binge eating disorder, to determine cost-effectiveness, and to identify predictors of treatment outcome.
Evidence will be gathered regarding whether this treatment will help to prevent excessive weight gain. If efficacy can
be demonstrated, the results from this trial will enhance availability of evidence-based treatment of adolescent binge
eating disorder.
Trial registration: German Clinical Trials Register: DRKS00000542
Keywords: Adolescents, Binge eating disorder, Cognitive-behavioral therapy, Randomized-controlled trialBackground
Binge eating disorder (BED), a provisional category in
the Diagnostic and Statistical Manual of Mental Disorders
Fourth Edition (DSM-IV-TR) [1], was approved in the fifth
revision DSM-5 [2] as its own diagnostic category of eating
disorder. BED is characterized by recurrent binge eating
that occurs, in contrast to the binge eating in bulimia
nervosa (BN), in the absence of regular inappropriateCorrespondence: anja.hilbert@medizin.uni-leipzig.de
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reproduction in any medium, provided the orcompensatory behavior to prevent weight gain (e.g.,
self-induced vomiting). BED has been identified in 1.6%
of 13- to 18-year-old adolescents from the community
[3], and in up to 25% of treatment-seeking adolescents
[4,5]. However, it is still debated as to whether the DSM
diagnostic criteria adequately capture the presentation
of BED in children and adolescents. For example, beyond
objective binge eating as defined in the DSM criteria of
BED (i.e., loss of control over eating a significantly large
amount of food) [2], a substantial proportion of adolescents
report subjective binge eating that is not part of the DSM
diagnostic criteria of BED (i.e., loss of control over eating ahis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cally relevant [4,6] (both types of binge eating are hereafter
referred to as binge eating). In addition, lowered diagnostic
thresholds have been proposed for the diagnosis of BED in
youth [7,8]. Subthreshold BED was found to be associated
with marked impairment and increased risk of developing
a full-syndrome presentation over time [9].
Similar to BED in adults, this disorder in adolescence is
associated with increased eating disorder psychopathology
(e.g., weight concern) and general psychopathology (e.g.,
depression, anxiety), impaired quality of life, and overweight
and obesity [4,10,11]. BED and its associated eating
disorder and general psychopathology were found to be
longitudinally predicted by binge eating in youth [12-14].
As postulated by maintenance theories of binge eating
developed for adults [15,16] and validated for youth [17],
binge eating in youth may be maintained through negative
affect and difficulties in regulating these mood states
[18-20]. Weight-related teasing and a negative body image
were closely linked with greater binge eating in youth
[21-23]. Further, binge eating emerges in the context of
increased impulsivity, irregular meal patterns, and interper-
sonal problems such as dysfunctional family interactions
[24-27]. These results suggest that patterns of non-norma-
tive eating behavior, difficulties in regulating negative
emotional states, a negative body image, and interpersonal
problems are important targets of intervention.
Of great concern are findings that youth with binge
eating or BED show increased weight gain and obesity
onset over time [14,28-31]. Given the psychological, social,
and medical sequelae of obesity [32,33], the risk of tracking
the excess body fat and comorbidities into adulthood
[34,35], and the associated health-care costs [36], it is
of the highest relevance to develop efficacious interventions
for the treatment of BED in adolescents to alleviate this
disorder’s symptomatology and to prevent excessive weight
gain.
Related to the recency of research about BED in ado-
lescence, there is a lack of validated treatments for this
age group. For adults with BED, cognitive-behavioral
therapy (CBT) is the most well-established psychological
treatment, as reflected in systematic reviews [37-39],
meta-analysis [40], and clinical guidelines [41], although
superiority to other bona fide treatments has not been
demonstrated clearly [42]. Efficacy studies of CBT docu-
mented substantial reductions in binge eating and associ-
ated symptomatology that can be maintained over the
long-term [43]. There is also evidence that patients
who achieve abstinence from binge eating lose a small but
significant amount of weight when compared to those
who remain symptomatic [44,45].
Among the few studies evaluating CBT or other psycho-
logical treatments for adolescents with recurrent binge
eating, CBT was in a pilot randomized-controlled trial(RCT) compared with a delayed treatment control condi-
tion. This CBT trial was efficacious in yielding abstinence
from recurrent binge eating over a three-month follow-up
in 12- to 18-year-old adolescents (n = 26) [46]. In addition,
concerns about shape, weight, and eating were significantly
reduced. The age-adapted CBT manual comprised eight
individual sessions over 3 months on nutritional manage-
ment, weight control, and body image, and up to four
optional sessions on food and mood and interpersonal
relationships. Another study focused on an Internet-based
mode of treatment delivery: a 16-week Internet-based
intervention program using CBT-principles (among other
principles) was part of a waiting-list (WL) controlled
randomized study. The Internet program was found to be
efficacious in facilitating weight loss or weight maintenance,
and reducing recurrent binge eating and shape and weight
concerns, in overweight adolescents over a 5-month follow-
up period (n = 105) [47]. In addition, a small-scale (n = 38)
randomized-controlled pilot study demonstrated feasibility
of 12-week group interpersonal psychotherapy in 12- to
17-year-old adolescent girls at risk for overweight, with
about half of the patients suffering from binge eating [48].
The results also suggested that interpersonal psychotherapy
reduced binge eating at 3-month follow-up and led to bet-
ter weight maintenance than a standard health education
group at 9-month follow-up. Further evidence is available
on CBT or CBT-based guided self-help for adolescents
with BN or with mixed eating disorder diagnoses [49,50],
providing support for CBT-based treatment in the related
eating disorder of adolescent BN. Thus far, however,
confirmatory evidence on the efficacy of psychological
treatments for BED in adolescents is lacking, moderators
and mediators are unknown, and cost-effectiveness has
not been evaluated.
In this context, the aim of the Binge Eating Disorder in
Adolescents (BEDA) study is to adapt an established CBT
manual for adult BED to adolescent BED, and evaluate its
short- and long-term efficacy, relative to a WL control
condition in a single-center randomized trial. Additional
objectives are to identify outcome predictors (moderators
and mediators) and to evaluate cost-effectiveness.
Methods/design
Hypotheses
(1)Age-adapted individual CBT will be superior to WL
in reducing the number of binge eating episodes in
adolescents with BED 4 months following
randomization.
(2)Age-adapted individual CBT will be superior to WL
in reducing the number of days with binge eating
episodes; leading to greater abstinence from binge
eating; reducing eating disorder psychopathology
and the severity of depressive symptoms; increasing
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mass index. The therapeutic gains will occur at
mid-treatment and will be maintained at 6 and 12
months following CBT.
(3)Age adapted individual CBT will be cost-effective.
Design, participants, and procedures
Study design
BEDA is a single-center, prospective, randomized super-
iority trial, evaluating the efficacy and cost-effectiveness of
CBT (experimental condition) compared to a WL control
condition. The study design is depicted in Figure 1. The
study period lasts 4 months per patient in the experimental
condition (4 months of CBT) and 8 months in the control
condition, including 4 months of WL and 4 months of
CBT; each patient is offered individual CBT. Using an
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Figure 1 Study design.2 months after randomization (mid-CBT; mid-WL), 4
months after randomization (post-CBT; post-WL or pre-
CBT/WL), and at 6- and 12-months follow-up after the
end of treatment (6-fu CBT, 12-fu CBT; 6-fu CBT/WL,
12-fu CBT/WL). The patients in the WL condition are
assessed additionally 2 months (mid-CBT/WL) and 4
months (post-CBT/WL) after the end of the waiting
period (i.e., after post-WL or pre-CBT/WL).
Participants
A total of 60 12- to 20-year-old adolescents meeting
age-adapted DSM criteria of BED will be randomized to
either CBT (n = 30) or WL (n = 30). Inclusion criteria are
summarized below. Based on the evidence on classification
of BED in youth (see Introduction), age-adapted diagnostic
criteria of BED are used in order to determine: BED
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DSM-5 based on objective and/or subjective episodes of
binge eating or Subthreshold BED according to DSM-5. To
ensure generalization of study results, exclusion criteria are
kept to a minimum.
Inclusion and exclusion criteria
Inclusion:
 Age 12–20 years
 Diagnosis of BED according to age-adapted DSM criteria;
 BED (DSM-IV-TR): At least 2 days with
objective and/or subjective episodes of
binge eating per week over the past 6 months;
at least 3 out of 5 behavioral indicators;
marked distress; absence of regular
compensatory behaviors to avoid weight
gain; absence of anorexia nervosa and BN;
 BED (DSM-5): At least 1 episode of objective
and/xor subjective episodes of binge eating
per week over the past 3 months; at least 3 out
of 5 behavioral indicators; marked distress;
absence of regular compensatory behaviors
to avoid weight gain; absence of anorexia
nervosa and BN;
 Subthreshold BED (DSM-5). All DSM-5 criteria
for BED are met, except the binge eating occurs
on average less than once a week and for less than
3 months.
 Written informed consent of parent and
adolescent for adolescents ages <18 years,




 Current substance abuse;
 Current suicidal ideation;
 Psychotic disorder;
 Bipolar disorder;
 Serious unstable medical problems or conditions
(e.g., type 1 diabetes mellitus or thyroid problems);
 Current intake of antipsychotic or weight-affecting
drugs;
 Current psychotherapy;
 Inpatient psychiatric treatment within the past 3
months prior to screening;
 Current conservative weight loss treatment;
 Female adolescents in pregnancy or lactation;
 Lack of compliance with major study procedures;
 Current participation in another treatment trial.Ethical approval
The study was approved by the Ethical Committee at
the University of Leipzig Medical Center. Written in-
formed consent of at least one parent and informed con-
sent of the adolescent are obtained for adolescents <18
years after the study has been fully explained. For ado-
lescents ≥18 years, written informed consent of the ado-
lescent only is required. Patients and their parents can
withdraw at any point without any penalty. The trial will
be conducted in accordance to the guidelines for Good
Clinical Practice [51]. All persons participating in the
conduct of the trial commit themselves to the Declaration
of Helsinki (Version Somerset West 1996) [52], as well as
all pertinent national laws and the International Confer-
ence on Harmonization guidelines for Good Clinical Prac-
tice and CPMP/ICH/135/95 (Note for Guidance on Good
Clinical Practice) [53].
Recruitment
The ongoing study is conducted from September 2011
at the Outpatient Unit of the Integrated Research and
Treatment Center (IFB) AdiposityDiseases at University
of Leipzig Medical Center, Leipzig, Germany. Recruit-
ment strategies include population-based recruitment
(e.g., information letters to households with children in
the targeted age range, website http://www.ess-stress.de),
school-based recruitment (e.g., educational classes,
screening), and recruitment in clinical settings (e.g., IFB
Outpatient Unit, behavioral weight loss facilities).
Procedures
Adolescents are screened by telephone for eligibility in
the study. Eligible adolescents and at least one parent
are invited to the IFB Outpatient Unit for a diagnostic
visit. At the outset of this visit, informed consent is gath-
ered in a written format as described. At baseline assess-
ment, inclusion and exclusion criteria are evaluated
using the clinical interviews described below. Addition-
ally, sociodemographic, anamnestic, anthropometric, and
clinical data, and health economic parameters, are
obtained using interviews, self-report-questionnaires, and
objective measurement as described below. After base-
line assessment, included patients are centrally random-
ized into the CBT or WL arm. Following randomization
into the CBT arm, patients are offered treatment over 4
months. Following randomization into the WL arm,
patients are invited to CBT over 4 months, after a
waiting-list period of 4 months.
Intervention
Experimental intervention – Cognitive-behavioral therapy (CBT)
An age-appropriate CBT manual was developed in order
to target the above-mentioned psychopathology and
maintenance factors of BED in adolescents. This adapted
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adult manual “Binge eating and obesity: Manual for the
treatment of binge eating disorder” by Hilbert and
Tuschen-Caffier [54]. This manual for adult BED was
piloted in an RCT [55] and is currently used in a multi-
center RCT comparing it to Internet-based guided self-
help [56]. Recovery and clinically significant improvement
rates of the pilot data lay within the range of those deter-
mined by other clinical trials evaluating the efficacy of
CBT in the treatment of BED [40].
The age-adapted manual for adolescents with BED differs
from the adult manual in several aspects: greater focus
on less complex, motivating behavioral exercises; decreased
focus on cognitive interventions; concentration on age-
specific maintenance factors (e.g., difficulties in identity
development) including familial factors (e.g., familial eating
patterns, family conflict); and a greater focus on enhancing
an autonomous motivation for treatment, since adolescents
may not necessarily be motivated for treatment and/or
treatment may be sought by third parties (e.g., parents).
All adolescent patients are guaranteed confidentiality
regarding their parents unless they provide information
that meets criteria for mandated reporting. Although
family-based treatment is efficacious in adolescent BN
[57], parental involvement in adolescent treatment for
bulimic eating disorders may decrease compliance [46,50];
thus, treatment is individually focused on adolescents.
Parents receive standardized information letters about
BED, general intervention topics, and recommendations
for daily routine on a monthly basis.
The age-adapted CBT manual includes the following
phases: (1) initial treatment phase for motivational en-
hancement; (2) intensive treatment phase including
modules on eating behavior, body image, and stress; and (3)
self-management phase for relapse prevention. Therapeutic
phases, goals, and techniques are depicted in Table 1.
The age-adapted CBT with the adolescent lasts 4
months and comprises 20 individual face-to-face sessions
(50 min) with the adolescent. Within the first month of
treatment, two sessions per week are scheduled (sessions
1–8), and in months 2 to 4 one session per week is
scheduled (sessions 9–20). CBT treatment is provided
by at least three clinical psychologists with advanced
training in behavior therapy and a specific training in
CBT of BED. Treatment fidelity is ensured through a
specific training in the CBT manual and regular super-
vision, which will also prevent drift in treatment deliv-
ery. Patients are allocated to therapists according to
their availability, and each therapist will see eight or
more patients. Treatment fidelity and therapist adherence
will be established using continuous adherence controls
based on audio documentation of the psychotherapeutic
sessions by two independent, trained raters using five
(25% of sessions) randomly-selected tapes per patient. Therating system is specific for CBT of eating disorders, and
was developed and evaluated in an independent clinical
study of CBT for adults with BED [Brauhardt et al.;
unpublished data].Control intervention – waiting list (WL)
Half of the patients will be randomly assigned to a WL
control condition. All WL patients are guaranteed individ-
ual CBT after a waiting period of 4 months (equal to the
duration of CBT). The WL patients are instructed not to
seek any other medical or psychological treatment for BED
or obesity during the WL period without informing the
project leader.Measures
Primary and secondary outcomes
The primary outcome measure is the number of binge
eating episodes over the previous 28 days 4 months after
randomization (post-CBT, post-WL), which is a standard
measure within treatment trials of adult BED [40]. The
number of binge eating episodes is assessed with the
German version of the Eating Disorder Examination (EDE)
[58-60], a validated semi-structured interview regarded as
the gold standard for the diagnosis and psychopathological
assessment of eating disorders. If necessary, age-adapted
language is used from the child version of the EDE [61,62].
For adult BED, it is common to determine the difference
in the number of episodes or days with objective binge
eating between baseline and follow-up and test for a
difference between a treatment and control group [40].
In adolescents, this measure has severe disadvantages
since the large variance in the number of episodes with
binge eating (i.e., objective and objective binge eating
[47,48]) can result in imbalances between randomized
arms (e.g., [47]). Abstinence rates, another typical measure
in treatment trials for adult BED [40], have the disadvantage
that patients who reduce their binge eating substantially,
but not completely, are treated as failures. Hence, we
chose to consider the ratio of the number of binge eating
episodes at 4 months after randomization to the number
at baseline as primary outcome criterion.
Secondary outcome measures include the number of
binge eating episodes 2 months after randomization
(mid-CBT, mid-WL), and maintenance of treatment suc-
cess regarding the number of binge eating episodes at 6
and 12 months following CBT (6-fu CBT, 12-fu CBT).
Additional secondary outcomes are also measured at 2 and
4 months after randomization and at 6 and 12 months
following CBT: the number of days with binge eating;
abstinence (i.e., zero binge eating episodes) from binge
eating; eating disorder psychopathology (all determined
through the EDE); additional aspects of non-normative
eating behavior as determined through the Dutch Eating
Table 1 Therapeutic phases, goals, and techniques
Therapeutic goals Techniques
Initial treatment phase (Sessions 1 – 3)
Initial contact and cognitive preparation - To establish a positive therapeutic alliance - Exploration
- To enhance motivation - Information on disorder and treatment
- To plan therapy - Goal setting
- Self-monitoring of eating behavior
- Self-management and self-reinforcement
Intensive treatment phase (Sessions 4 – 18)
Eating behavior module “My Nutrition” - To establish a healthy eating behavior - Information on nutrition and physical activity
- Self-monitoring of eating behavior and physical
activity
- Goal setting
- Stimulus and response control
- Cue exposure
- Eating hedonics exercises
- Self-management and self-reinforcement
- Cognitive restructuring
- Homework
Body image module “My Body” - To establish a positive body image and
weight maintenance
- Information on body image and weight-related
stigmatization
- Body image exposure
- Self-monitoring of negative body talk
- Self-monitoring of physical activity
- Shaping of regular physical activity
- Body hedonics exercises
- Self-management and self-reinforcement
- Cognitive restructuring
- Homework
Stress module “My Emotions” - To identify and treat related psychopathology
(e.g., emotion regulation difficulties, stress
management problems, interpersonal conflict,








- Self-management and self-reinforcement
- Cognitive restructuring
- Homework
Self-management phase (Sessions 19 – 20)
- To stabilize progress - Review of progress
- To prevent relapse - Goal setting regarding future work
- Identification of situations and signs of risk for
relapse and delineation of an emergency plan
- Self-management and self-reinforcement
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http://www.trialsjournal.com/content/14/1/312Behavior Questionnaire [63,64]; the severity of depressive
symptoms [65,66]; self-esteem [67,68]; quality of life [69,70],
and body mass index (BMI, kg/m2). Body weight and
height is objectively measured through calibrated in-
struments. Psychiatric comorbidity is determined per
structured clinical interview K-DIPS [71] 6 and 12 months
following CBT.
We chose these outcome measures because they ex-
hibit good psychometric properties in the respective age
group, are well-established in German, and are used in
international research studies. The structured clinical
interviews EDE and K-DIPS are conducted by trained
raters. All raters are blind to study hypotheses and
randomization, and have no therapeutic relationship with
the patients. They underwent extensive training for con-
ducting the interviews and receive ongoing supervision
for standardized administration (drift prevention).
Cost effectiveness
Health resource utilization and loss of productivity is
assessed using the Client Sociodemographic and Service
Receipt Inventory [72], adapted for the purposes of this
study. The self-report questionnaire is administered at all
assessment time points specified above.
Predictor variables
Potential predictor variables, assessed at baseline, consist
of outcome variables, sociodemographic and anamnestic
variables, and patient motivation and expectation ratings
assessed through visual analogue scales. The predictor
(moderator) variables will be selected based on the
literature or on our theoretical understanding of the mode
of action of the treatment.
Process variables
For exploratory identification of mediators, process mea-
sures are obtained by the patient every week of treatment.
These consist of a selection of items of the self-report




RCTs analyzing the reduction of binge eating episodes by
interpersonal psychotherapy [48], an Internet-based CBT
program [47], and adolescent-specific CBT [46] provide
rough estimates for baseline situations and treatment
effects. In these studies, variances in the number of binge
eating episodes are large and abstinence rates vary consid-
erably. Simulation of treatment effects that was repeated
5,000 times demonstrated that a power of 95% can be
reached with n = 27 individuals per group using a t-test
(α = 0.05). With an assumed overall dropout rate of 10%
of study patients (range: 0 to 11.5%) [47,48], 30 patientsshould be recruited per study group. While assuming
this dropout rate, every effort is made to retain as many
participants as possible throughout the period of the study,
including providing information to participants on the
relevance and necessity of the study, the use of continuity
forms locating participants throughout the study period,
and use of incentives for follow-up assessments.
Randomization
Adolescents who meet the respective criteria and who
give informed consent (and for adolescents aged <18 years
whose parents give informed consent) are randomized. To
ensure concealment of allocation, the randomization is
centrally performed by the Coordination Center for
Clinical Trials of the University of Leipzig. Randomization
is computer-assisted, using Pocock’s minimization algorithm
[76]. The randomization is stratified by sex and age (12 to
15 and 16 to 20 years). The allocation ratio between the
two arms of the study is 1:1.
Blinding
Outcome assessments are performed by independent
raters who have no therapeutic relationship with the pa-
tients and are blind to study hypotheses and randomization.
Blinding of patients and treatment is not possible in this
trial, as both therapists and patients know the study arm
from the particular modes of delivery.
Data analytic plan
The primary outcome “reduction in the number of binge
eating episodes over the previous 28 days 4 months after
randomization” will be investigated with analysis of
covariance using the ratio as the dependent variable (the
number of binge eating episodes at 4 months following
randomization divided by the number at baseline), treat-
ment group as factor and the inverse number of binge
eating episodes at baseline as a covariate based on the
full analysis set [77]. The full analysis set includes all
randomized patients, regardless of whether or not they
provide data at follow-up. Further, the analysis of the
number of binge eating episodes will be performed in
the per protocol set to evaluate the treatment effect for
patients with good protocol adherence. In addition, the
maintenance of treatment effects regarding the number of
binge eating episodes will be analyzed in the framework
of random coefficients modeling. Random coefficients
modeling is state of the art in the analysis of eating disorder
treatment effects, as it can incorporate heterogeneity of
effects (by treatment moderator) and is tolerant of missing
data.
Secondary outcome measures will be analyzed in an
exploratory manner and will be evaluated by means of
parametric or non-parametric tests, depending on the given
scale level and type of distribution of the observed
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ated by random coefficient models. For all outcomes, ef-
fect sizes will be estimated and presented with 95%
confidence intervals. Predictors of treatment outcome
(moderators and mediators) will be identified in an ex-
ploratory manner using multivariable analyses.Monitoring and data management
The trial is performed in cooperation with the Coordination
Center for Clinical Trials of the University of Leipzig,
which is responsible for monitoring and data management.
Data are monitored for completeness, consistency, and
plausibility. Errors in data entry are determined in a
step-wise procedure, examining all data of five patients
and, depending on error rates, examining all data in up to
an additional 25% of the patients. Data quality is ensured
through plausibility checks (e.g., examination of ranges).
Post-treatment data will be released only after study
completion (i.e., after termination of the 12-months follow-
up). No interim analyses are planned.
The study data will be reported in accordance with the
extended Consolidated Standards of Reporting Trials guide-
lines for non-pharmacological treatment studies [78].Safety aspects
Adverse events are all unwanted medical events (e.g.,
emerging or aggravating symptoms) occurring throughout
the trial whether or not they have a causal association with
the trial. Adverse events will be documented at every
assessment and at every week of treatment throughout
the trial. They are rated regarding their severity: serious
adverse events are those having led to death, that are
life-threatening, make inpatient treatment necessary,
lead to sustained harm, or cause birth defects or deform-
ities. Serious adverse events include mental or physical
decompensations that indicate a need for hospitalization
(e.g., acute suicidality). Adverse events are recorded through
a self-report assessment of somatic symptoms [79,80] at
every assessment and an unstandardized reporting of
adverse events every week during treatment. In addition,
adverse events are assessed systematically at post-treatment
using a self-report scale for the assessment of negative
effects of psychotherapy [INEP, “Inventar zur Erfassung
Negativer Effekte von Psychotherapie” Ladwig et al.; un-
published manuscript].
An independent Data Monitoring and Safety Committee
(DMSC) was established to meet once per year for inde-
pendent study supervision. The DMSC is composed of
three researchers with expertise in the area of the study.
The type of information monitored includes patient re-
cruitment, number of dropouts, and all adverse events
including study withdrawals. Any serious adverse event
will be immediately reported to the Ethical Committeeat the University of Leipzig Medical Center and will be
forwarded to the DMSC. The DMSC receives recruitment
and retention updates on a regular basis.Discussion
Recent evidence indicates that a substantial proportion
of adolescents suffer from BED and associated psychopath-
ology. Additionally, they are at risk of excessive weight gain,
overweight, and obesity, with increased risk of associated
medical sequelae. As the research interest in adolescent
BED has been growing only recently, there is a lack of
evidence-based psychological treatments for BED in this
age group. One randomized pilot study demonstrated
feasibility and suggested potential efficacy of a brief indi-
vidual CBT for binge eating and associated psychopath-
ology [46]; another randomized clinical trial showed
that an Internet-based program based on CBT principles
(among other principles) was efficacious in facilitating
weight loss or weight maintenance, and reducing binge
eating and shape and weight concerns in overweight
adolescents with recurrent binge eating [47]. Both trials
included mixed populations of recurrent binge eaters:
compensatory behaviors [47] and/or BN [46] were not ex-
cluded, and binge eating frequently lay below the diagnostic
threshold of BED [46]. Both trials suggested maintenance
of effects over a short-term follow-up period of three
to five months. Since CBT is the most well established
psychological treatment of adult BED, an examination
of the short-term and long-term efficacy of individual
CBT specific for adolescent BED is a logical next step of
research.
In this study, an evidence-supported CBT manual for
adult BED was adapted for adolescents and is subjected
to a confirmatory efficacy test comparing individual CBT
to a WL control condition in a randomized psychotherapy
trial with a follow-up period of one year. An extension of
this long-term follow-up is planned, but will depend on
organizational requirements after the end of the funding
period. If efficacy can be demonstrated, the results from
this trial will enhance availability and foster dissemination
of evidence-based treatment of adolescent BED. Beyond
the effects on BED and associated psychopathology,
evidence will be gathered to determine if this treatment
will also help to prevent excessive weight gain. The study
will further allow for the identification of individuals
for whom (moderators) CBT will work and allow for clari-
fication of which mechanism (mediators) changes will be
entailed. Such results would advance decisions for matching
adolescents with BED into CBT, and may inform technical
aspects of intervention conduct.Trial status
This study is ongoing and will continue until April 2015.
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